Patients with advanced stage of neuroendocrine tumor represent that the tumor cells have begun to metastasize to lymph nodes and distant organs, and the condition is more serious, which will seriously affect the patients’ life.
Neuroendocrine tumors belong to well-differentiated neuroendocrine tumors, which can be classified into G1 and G2 grades. They often progress slowly and are not easy to be detected, but can still infiltrate to the surrounding and distant places and endanger the patients’ lives if not actively treated.
Biological therapy and targeted therapy can be used for advanced stage patients. Biological therapy drugs are mainly growth inhibitor analogs, including octreotide and lanreotide, etc.; targeted drugs include mammalian target protein inhibitor of rapamycin, everolimus, and receptor tyrosine kinase inhibitor, sunitinib, etc.
Patients diagnosed with advanced neuroendocrine tumors should actively cooperate with doctors for treatment and build up confidence in treatment, which will help improve the prognosis.